These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8801621)

  • 1. Concluding remarks on the proposed safety appraisal framework for evaluating macronutrient substitutes.
    Allgood G
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S60-1. PubMed ID: 8801621
    [No Abstract]   [Full Text] [Related]  

  • 2. Panel discussion: what is the future of macronutrient substitutes in North America?
    Borzelleca JF; Cheney M; Davidson MH; Degnan FH; Derfler PS; Forbes AL; Glinsmann W; Heckman JH; Miller SA; Rulis AM; Masten LW
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S51-9. PubMed ID: 8801619
    [No Abstract]   [Full Text] [Related]  

  • 3. Macronutrient substitutes: are regulatory options possible?
    Degnan FH
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S38-41. PubMed ID: 8801616
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory aspects of the introduction of new macronutrient substitutes.
    Rulis AM; Pellicore LS; Thorsheim HR
    Ann N Y Acad Sci; 1997 May; 819():22-8. PubMed ID: 9186757
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction: safety and regulatory issues related to the use of macronutrient substitutes in the food supply.
    Masten LW
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S3-5. PubMed ID: 8801615
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the workshop on safety and regulatory aspects of macronutrient substitutes. Washington, D.C., November 16, 1994.
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S1-62. PubMed ID: 8801609
    [No Abstract]   [Full Text] [Related]  

  • 7. A proposed model for safety assessment of macronutrient substitutes.
    Borzelleca JF
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S15-8. PubMed ID: 8801610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Government should strengthen regulation in the weight loss industry.
    Begley CE
    J Am Diet Assoc; 1991 Oct; 91(10):1255-7. PubMed ID: 1918746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of macronutrient substitutes by the Food and Drug Administration.
    Rulis AM
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S47-50. PubMed ID: 8801618
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmarket surveillance to determine nutritional impact of macronutrient substitutes.
    Cheney M
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S22-4; discussion S31-7. PubMed ID: 8801612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative approaches to the safety assessment of macronutrient substitutes.
    Munro IC; McGirr LG; Nestmann ER; Kille JW
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S6-14. PubMed ID: 8801620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteral solutions: is there a solution?
    Heymsfield SB
    Nutr Clin Pract; 1995 Feb; 10(1):4-7. PubMed ID: 7898417
    [No Abstract]   [Full Text] [Related]  

  • 13. It's a food, it's a drug ... no, it's a medical food.
    King AB
    Nutrition; 1997 Mar; 13(3):247-8. PubMed ID: 9131695
    [No Abstract]   [Full Text] [Related]  

  • 14. The need for human data: the role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes.
    Forbes AL
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S20-1; discussion S31-7. PubMed ID: 8801611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The danger in food safety policies.
    Hall RH
    Can Med Assoc J; 1978 Jan; 118(1):83-7. PubMed ID: 620390
    [No Abstract]   [Full Text] [Related]  

  • 16. Remarks of the Commissioner of Food and Drugs.
    McClellan MB
    Food Drug Law J; 2003; 58(2):191-204. PubMed ID: 12866552
    [No Abstract]   [Full Text] [Related]  

  • 17. Remarks delivered at the Food and Drug Law Institute's 48th Annual Conference.
    Enzi MB
    Food Drug Law J; 2005; 60(2):103-6. PubMed ID: 16097090
    [No Abstract]   [Full Text] [Related]  

  • 18. Remarks of the acting FDA commissioner: FDLI's 47th annual conference.
    Crawford LM
    Food Drug Law J; 2004; 59(2):201-8. PubMed ID: 15318391
    [No Abstract]   [Full Text] [Related]  

  • 19. Are fake fats and sugars for real?
    Yen P
    Geriatr Nurs; 1990; 11(4):204-5. PubMed ID: 2163961
    [No Abstract]   [Full Text] [Related]  

  • 20. Nutritional optimization of new foods.
    Rosenfield D
    J Am Diet Assoc; 1978 May; 72(5):475-7. PubMed ID: 649894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.